Gyre Therapeutics, Inc.
GYRE
$7.01
-$0.64-8.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 52.43M | 60.05M | 54.37M | 29.89M | 26.67M |
| Total Receivables | 36.95M | 26.80M | 25.36M | 22.52M | 29.15M |
| Inventory | 10.17M | 8.85M | 8.86M | 7.88M | 6.34M |
| Prepaid Expenses | 1.34M | 2.87M | 2.70M | 8.16M | 1.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.49M | -- | -- | -- | 1.44M |
| Total Current Assets | 102.37M | 98.58M | 91.29M | 68.45M | 64.79M |
|
|
|||||
| Total Current Assets | 102.37M | 98.58M | 91.29M | 68.45M | 64.79M |
| Net Property, Plant & Equipment | 24.73M | 24.91M | 24.90M | 25.12M | 25.70M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.15M | 4.85M | 4.96M | 5.08M | 1.71M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.77M | 10.74M | 9.97M | 9.77M | 7.05M |
| Total Assets | 166.13M | 159.38M | 152.65M | 129.79M | 125.41M |
|
|
|||||
| Total Accounts Payable | 124.00K | 556.00K | 71.00K | 122.00K | 108.00K |
| Total Accrued Expenses | 12.09M | 9.46M | 12.73M | 9.58M | 9.30M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 636.00K | 626.00K | 622.00K | 805.00K | 713.00K |
| Total Finance Division Other Current Liabilities | 5.44M | 5.27M | 3.49M | 8.48M | 9.39M |
| Total Other Current Liabilities | 5.44M | 5.27M | 3.49M | 8.48M | 9.39M |
| Total Current Liabilities | 18.29M | 15.91M | 16.92M | 18.99M | 19.52M |
|
|
|||||
| Total Current Liabilities | 18.29M | 15.91M | 16.92M | 18.99M | 19.52M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 303.00K | 539.00K | 771.00K | 780.00K | 885.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.26M | 5.52M | 5.51M | 5.72M | 6.60M |
| Total Liabilities | 23.85M | 21.97M | 23.20M | 25.49M | 27.00M |
|
|
|||||
| Common Stock & APIC | 172.14M | 167.23M | 161.53M | 138.27M | 136.27M |
| Retained Earnings | -65.33M | -63.61M | -67.22M | -67.66M | -70.36M |
| Treasury Stock & Other | -779.00K | -1.70M | -2.29M | -2.49M | -2.60M |
| Total Common Equity | 106.03M | 101.92M | 92.03M | 68.12M | 63.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 106.03M | 101.92M | 92.03M | 68.12M | 63.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 36.25M | 35.50M | 37.42M | 36.18M | 35.08M |
| Total Equity | 142.28M | 137.42M | 129.44M | 104.30M | 98.40M |
|
|
|||||